"Still Rather Hazy at Present": Citizens' and Physicians' Views on Returning Results from Biobank Research Using Broad Consent. - PubMed - NCBI

"Still Rather Hazy at Present": Citizens' and Physicians' Views on Returning Results from Biobank Research Using Broad Consent. - PubMed - NCBI

Genet Test Mol Biomarkers. 2017 Mar;21(3):159-165. doi: 10.1089/gtmb.2016.0412. Epub 2017 Feb 8.

"Still Rather Hazy at Present": Citizens' and Physicians' Views on Returning Results from Biobank Research Using Broad Consent.

Barazzetti G1,2, Cavalli S1, Benaroyo L3, Kaufmann A4.

Author information

Abstract

AIMS:

Informed consent and return of research results are among the most debated topics in the biobank literature. We discuss ethical, social, and policy issues associated with returning results in the context of biobanks using a broad consent approach, in the light of data from a qualitative survey of citizens' and physicians' views.

MATERIALS AND METHODS:

Data were collected through interviews and focus groups to investigate stakeholders' perspectives about a large-scale hospital-based biobank designed to foster biomedical research, including prospective genomics research, and "personalized" medicine.

RESULTS:

Both physicians and citizens considered psychosocial impacts as crucial in the assessment of benefits expected from a return of results to biobank participants. In particular, physicians highlighted the possible consequences on the patient-doctor relationship and discussed implications for the concept of "personalized" medicine. Citizens held ambivalent attitudes toward returning individual research results: they defended the "right not to know," while they also considered a sort of "responsibility to know" because of potential implications of results for family members. Moreover, physicians and citizens raised questions about the broad consent model used for inhospital biobank recruitment and expressed their needs for more training in genomics and more information on the biobank initiative.

CONCLUSIONS:

Stakeholders such as citizens and physicians, who may be concerned as potential biobank participants or as healthcare professionals involved in the management of clinically relevant research results, provide useful insights into several aspects of broad consent and return of results, related in particular to the interface between research and the clinic.

KEYWORDS:

biobank; broad consent; return of results

PMID:

 

28177781

 

DOI:

 

10.1089/gtmb.2016.0412

[Indexed for MEDLINE]

Last Posted: Mar 30, 2017

---

• "Still Rather Hazy at Present": Citizens' and Physicians' Views on Returning Results from Biobank Research Using Broad Consent.  
  Barazzetti Gaia et al. Genetic testing and molecular biomarkers 2017 Mar 21(3) 159-165
• A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.  
  Vissers Lisenka E L M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Mar
• An Evidence Framework for Genetic Testing  
  NASEM report, March 27, 2017
• Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.  
   et al. Obstetrics and gynecology 2017 Apr 129(4) e96-e101
• Diagnostic Tests for Evaluation of Stillbirth: Results From the Stillbirth Collaborative Research Network.  
  Page Jessica M et al. Obstetrics and gynecology 2017 Apr 129(4) 699-706
• Impact of subsidies on cancer genetic testing uptake in Singapore.  
  Li Shao-Tzu et al. Journal of medical genetics 2017 Apr 54(4) 254-259
• Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.  
  Djordjevic Bojana et al. Surgical pathology clinics 2016 Jun 9(2) 289-99
• Panel-Based Clinical Genetic Testing in 85 Children with Inherited Retinal Disease.  
  Taylor Rachel L et al. Ophthalmology 2017 Mar
• Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?  
  Mitchell Gillian et al. Surgical pathology clinics 2016 Jun 9(2) 301-6
• The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.  
  Ackerman Marra G et al. The breast journal 2017 Mar
• Use of BRCA Mutation Test in the U.S., 2004-2014.  
  Guo Fangjian et al. American journal of preventive medicine 2017 Mar
• Adding value to genetic testing through utilization management: Commercial laboratory's experience.  
  Londre Gina K et al. American journal of medical genetics. Part A 2017 Mar
• Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic Reviews.  
  French David P et al. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2017 Mar
• Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.  
  Cragun Deborah et al. Expert review of molecular diagnostics 2017 Jan 17(1) 57-70
• Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.  
  Chokoshvili Davit et al. Best practice & research. Clinical obstetrics & gynaecology 2017 Feb
• Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium.  
  Chokoshvili Davit et al. Genetic testing and molecular biomarkers 2017 Mar 21(3) 195-201

more